Brown-Forman's 25% Rebound: Still Below Fair Value or Just a Trap?

Brown-Forman's rebound has reopened the value debate

The easy money from panic is gone. Brown-Forman has already rebounded sharply, with shares up 9.5% over the past week, 24.6% over the past month, and 12.0% year to date, even though they still sit 12.2% lower over the last year. That creates the central tension: bulls see a battered premium spirits business getting a second chance, while bears see a relief rally that may not yet be backed by a proven demand recovery.

That is why the value debate is back, not finished. A DCF screen still points to DCF Value per Share 35.45 USD, which implies the stock is still undervalued by 19%. In plain English, the market may still be pricing Brown-Forman as if the bad news can keep compounding, even after the rebound.

The next proof point is close: Brown-Forman reports first quarter fiscal 2027 results on September 2, 2026. So the decision now is not whether the stock looked cheap after the selloff. It is whether this rebound is strong enough, and early enough, to justify paying up before the turnaround is fully confirmed.

The bull case rests on stabilization, not a strong fiscal 2026

The bull case is not that fiscal 2026 looked good on paper. It was not. The bull case is that the reported numbers looked worse than the underlying business.

Reported results weakened more than demand

Brown-Forman finished the year with reported net sales decreased 1% to $3.9 billion and diluted earnings per share decreased 17% to $1.53. The fourth quarter looked even weaker, with fourth-quarter reported operating income decreased 53% and diluted earnings per share decreased 62%. That helps explain the market's nervous reaction.

But reported results can distort a spirits business when currency, mix, divestitures, and other items hit at once. The steadier read is underneath. For the full year, organic net sales were flat. In the fourth quarter, organic net sales increased 2% and organic operating income was flat. That does not look like a collapse in consumer demand; it looks more like a messy cleanup year.

Restructuring matters if it improves profit conversion

Management said fiscal 2026 benefited from the early benefits of its U.S. route-to-market transformation, along with strong execution in its innovation portfolio and strategic cost-restructuring initiatives.

If those fixes keep working into the next quarter, the same organic sales base could produce better operating income. That is the core of the bull case: not that 2026 was strong, but that the business may start looking cheaper as reported margins recover faster than demand does.

The bear case is that the rebound may have covered too much ground

A stock can look cheap relative to a model and still be expensive if the recovery is less certain than the model assumes.

The tape is no longer signaling panic

Brown-Forman's latest close was $28.52 as of Aug. 7, 2026. That is already above its 52-week average stock price of $27.47 and only 11.9% below the 52-week high of $31.92. The stock is still 20.7% above the 52-week low of $22.61. In other words, the market has already given the company meaningful credit for a comeback before the recovery is fully proven.

Bulls see stability; bears see fragile assumptions

The bull case is straightforward: the business held up better than the headlines suggested. Brown-Forman posted fourth-quarter reported operating income decreased 53% and diluted earnings per share decreased 62%, but those results came alongside fourth-quarter reported net sales increased 2%, which was +2% on an organic basis. Full-year sales also told a steadier story underneath the headlines: reported net sales decreased 1%, yet that was flat on an organic basis.

Bears do not need to argue that the business is broken. They only need to argue that DCF targets can be too generous when the earnings base is still being cleaned up. Valuation models start with forecasts, and a forecast made during a turnover period can overstate what the next normal earnings power really is. Even a model showing DCF Value per Share 35.45 USD can miss if margin recovery, mix, or currency assumptions prove too optimistic. That is the real bear argument: not permanent damage, but fragile assumptions dressed up as intrinsic value.

That is why waiting for confirmation is not a bad plan. If Brown-Forman can keep building evidence that organic demand is stable and the reported earnings mess is behind it, today's price may turn out to be reasonable. If not, the stock already has less room to de-rate before it starts looking expensive again.

September earnings are the real test

That is why the next step is not another valuation debate. It is a two-track test before and during September 2, 2026 earnings.

What would support the turnaround case

• Demand is holding. The clearest green light is another quarter where organic net sales were flat for the full year, or positive sales momentum in Q1, because that would suggest the brand engine is stable rather than still slipping.
• The cleanup is improving profit conversion. Management said fiscal 2026 benefited from the early benefits of its U.S. route-to-market transformation. If that shows up as better conversion from sales into earnings, the market can start paying a higher multiple for the same top line.
• Cash generation remains intact. Strong cash flow matters because a business with real cash generation can get through a tough cycle without stretching its balance sheet.

What would weaken the thesis

If management has to talk around the real issue, the stock's cheap label becomes much less useful. The main warning signs would be:

• weak Q1 organic sales
• no proof that distributor inventories are getting back to healthier levels
• margin recovery that looks borrowed rather than durable

For BF.B, that makes this a watch-for-confirmation setup: interesting if September turns a still-below-fair-value case into a proven recovery, but not a blind leap.